Search Results - "Gibo, Denise"

Refine Results
  1. 1

    New agents for targeting of IL-13RA2 expressed in primary human and canine brain tumors by Debinski, Waldemar, Dickinson, Peter, Rossmeisl, John H, Robertson, John, Gibo, Denise M

    Published in PloS one (16-10-2013)
    “…Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous…”
    Get full text
    Journal Article
  2. 2

    An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts by Pandya, Hetal, Gibo, Denise M., Garg, Shivank, Kridel, Steven, Debinski, Waldemar

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2012)
    “…Interleukin 13 receptor α 2 (IL-13Rα2) is a glioblastoma multiforme (GBM)-associated plasma membrane receptor, a brain tumor of dismal prognosis. Here, we…”
    Get full text
    Journal Article
  3. 3

    EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme by Wykosky, Jill, Gibo, Denise M, Stanton, Constance, Debinski, Waldemar

    Published in Molecular cancer research (01-10-2005)
    “…We investigated the presence of EphA2, and its ligand, ephrinA1, in glioblastoma multiforme (GBM), a malignant neoplasm of glial cells, and normal brain. We…”
    Get full text
    Journal Article
  4. 4

    A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor–expressing tumor cells by Wykosky, Jill, Gibo, Denise M, Debinski, Waldemar

    Published in Molecular cancer therapeutics (01-12-2007)
    “…We have previously shown that the EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive…”
    Get full text
    Journal Article
  5. 5

    Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy by Wykosky, Jill, Gibo, Denise M, Stanton, Constance, Debinski, Waldemar

    Published in Clinical cancer research (01-01-2008)
    “…We investigated the expression of interleukin-13 receptor alpha2 (IL-13R alpha 2), EphA2, and Fos-related antigen 1 (Fra-1) in astrocytomas and normal brain…”
    Get full text
    Journal Article
  6. 6

    EphrinA1 Is Released in Three Forms from Cancer Cells by Matrix Metalloproteases by Beauchamp, Amanda, Lively, Mark O., Mintz, Akiva, Gibo, Denise, Wykosky, Jill, Debinski, Waldemar

    Published in Molecular and Cellular Biology (01-08-2012)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells by Debinski, Waldemar, Gibo, Denise M

    Published in Molecular cancer research (01-04-2005)
    “…Malignant gliomas, and high-grade gliomas (HGG) in particular, are nonmetastasizing but locally infiltrating, hypervascularized brain tumors of poor prognosis…”
    Get full text
    Journal Article
  8. 8

    Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells by Debinski, Waldemar, Gibo, Denise M.

    Published in Cancer biology & therapy (15-01-2011)
    “…Fos-related antigen 1 (Fra-1) plays an important role in maintenance/progression of various cancers, including glioblastoma multiforme (GBM). In this study, we…”
    Get full text
    Journal Article
  9. 9

    Frame-Based Stereotactic Biopsy of Canine Brain Masses: Technique and Clinical Results in 26 Cases by Rossmeisl, John Henry, Andriani, Rudy T, Cecere, Thomas E, Lahmers, Kevin, LeRoith, Tanya, Zimmerman, Kurt L, Gibo, Denise, Debinski, Waldemar

    Published in Frontiers in veterinary science (27-07-2015)
    “…This report describes the methodology, diagnostic yield, and adverse events (AE) associated with frame-based stereotactic brain biopsies (FBSB) obtained from…”
    Get full text
    Journal Article
  10. 10

    Interleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy by Wykosky, Jill, Gibo, Denise M., Stanton, Constance, Debinski, Waldemar

    Published in Clinical cancer research (01-01-2008)
    “…Purpose: We investigated the expression of interleukin-13 receptor α2 (IL-13Rα2), EphA2, and Fos-related antigen 1 (Fra-1) in astrocytomas and normal brain. We…”
    Get full text
    Journal Article
  11. 11

    Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin by Liu, Tie Fu, Cai, Jiaozhong, Gibo, Denise M, Debinski, Waldemar

    Published in Clinical cancer research (01-01-2009)
    “…Purpose: Hypoxia is a cause for resistance to cancer therapies. Molecularly targeted recombinant cytotoxins have shown clinical efficacy in the treatment of…”
    Get full text
    Journal Article
  12. 12

    A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker by Nguyen, Van, Conyers, Jesse M, Zhu, Dongqin, Gibo, Denise M, Hantgan, Roy R, Larson, Steven M, Debinski, Waldemar, Mintz, Akiva

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2012)
    “…Our objective was to exploit a novel ligand-based delivery system for targeting diagnostic and therapeutic agents to cancers that express interleukin 13…”
    Get full text
    Journal Article
  13. 13

    IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications by Nguyen, Van, Conyers, Jesse M, Zhu, Dongqin, Gibo, Denise M, Dorsey, Jay F, Debinski, Waldemar, Mintz, Akiva

    Published in Translational oncology (01-12-2011)
    “…Abstract Glioblastoma multiforme (GBM) overexpresses interleukin 13 receptor α2 (IL-13Rα2), a tumor-restricted receptor that is not present in normal brain. We…”
    Get full text
    Journal Article
  14. 14

    Molecular targeting of intracellular compartments specifically in cancer cells by Pandya, Hetal, Gibo, Denise M, Debinski, Waldemar

    Published in Genes & cancer (01-05-2010)
    “…We have implemented a strategy in which a genetically engineered, single-chain protein specifically recognizes cancer cells and is trafficked to a targeted…”
    Get full text
    Journal Article
  15. 15

    Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2 by Mintz, Akiva, Gibo, Denise M, Madhankumar, A B, Cladel, Nancy M, Christensen, Neil D, Debinski, Waldemar

    Published in Cancer biotherapy & radiopharmaceuticals (01-10-2008)
    “…High-grade astrocytoma (HGA) is an invariably fatal malignancy with a mean survival of 14 months despite surgery, radiation, and chemotherapy. We have found…”
    Get more information
    Journal Article
  16. 16

    Novel anti-brain tumor cytotoxins specific for cancer cells by Debinski, Waldemar, Gibo, Denise M, Obiri, Nicholas I, Kealiher, Aynsley, Puri, Raj K

    Published in Nature biotechnology (01-05-1998)
    “…The vast majority of brain cancers (gliomas) express a receptor (R) for interleukin 13 (IL13). In order to achieve specific targeting of the IL13R in gliomas,…”
    Get full text
    Journal Article
  17. 17

    Receptor for Interleukin 13 Is a Marker and Therapeutic Target for Human High-Grade Gliomas by Debinski, W, Gibo, D M, Hulet, S W, Connor, J R, Gillespie, G Y

    Published in Clinical cancer research (01-05-1999)
    “…Glioblastoma multiforme (GBM) is an incurable brain tumor. Due to the striking heterogeneity that characterizes GBM, there is no known tumor-specific antigen…”
    Get full text
    Journal Article
  18. 18

    IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13 by Mintz, Akiva, Gibo, Denise M., Slagle-Webb, Becky, Christensent, Neil D., Debinski, Waldemar

    Published in Neoplasia (New York, N.Y.) (2002)
    “…We have found that binding sites for interleukin-13. ( IL13) are overexpressed in a vast majority of high-grade astrocytomas. (HGAs). These binding sites for…”
    Get full text
    Journal Article
  19. 19

    Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen by Debinski, W, Gibo, D M

    Published in Molecular medicine (Cambridge, Mass.) (01-05-2000)
    “…The vast majority of patients with high-grade gliomas (HGG) over-express interleukin 4 (IL4)-independent binding sites for IL13 in situ. In addition, mutated…”
    Get full text
    Journal Article
  20. 20

    BI-09EphA3 RECEPTOR IS A MOLECULAR TARGET EXPRESSED IN MULTIPLE COMPARTMENTS OF GBM by Ferluga, Sara, Gibo, Denise, Debinski, Waldemar

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…Eph receptor A3 belongs to the Eph family of receptor tyrosine kinases playing critical roles in cancer. We and others found this receptor to be over-expressed…”
    Get full text
    Journal Article